Evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) As Coronavirus Disease 2019 (COVID-19) Pandemic: A Global Health Emergency

Overview

Journal Sci Total Environ

Date 2020 May 7

PMID 32371230

Citations 204

Authors

Thamina Acter

Nizam Uddin

Jagotamoy Das

Afroza Akhter

Tasrina Rabia Choudhury

Sunghwan Kim

Affiliations

Soon will be listed here.

Abstract

According to data compiled by researchers at Johns Hopkins University in Baltimore, Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19), caused by a newly discovered virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been confirmed on April 20, 2020 (Nature, 2020b). Since the emergence of this infectious disease in Asia (Wuhan, China) late last year, it has been subsequently span to every continent of the world except Antarctica (Rodríguez-Morales et al., 2020). Along with a foothold in every country, the current disease pandemic is disrupting practically every aspect of life all over the world. As the outbreak are continuing to evolve, several research activities have been conducted for better understanding the origin, functions, treatments, and preventions of this novel coronavirus. This review will be a summa of the key features of novel coronavirus (nCoV), the virus causing disease 2019 and the present epidemic situation worldwide up to April 20, 2020. It is expected that this record will play an important role to take more preventive measures for overcoming the challenges faced during this current pandemic.

Citing Articles

The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2.

Khan T, Shahab M, Alharbi A, Waqas M, Zakirullah , Zheng G Sci Rep. 2025; 15(1):6482.

PMID: 39987216 PMC: 11847000. DOI: 10.1038/s41598-025-89548-2.

Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis.

Sharma G, Kumar N, Sharma C, Alqahtani T, Tiruneh Y, Sultana S Sci Rep. 2025; 15(1):2830.

PMID: 39843610 PMC: 11754916. DOI: 10.1038/s41598-025-86016-9.

Bayesian spatio-temporal modeling of severe acute respiratory syndrome in Brazil: A comparative analysis across pre-, during, and post-COVID-19 eras.

Souza Bulhoes R, Pimentel J, Rodrigues P Infect Dis Model. 2025; 10(2):466-476.

PMID: 39834649 PMC: 11743096. DOI: 10.1016/j.idm.2024.12.010.

Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in East Asia and the Pacific Region: Longitudinal Trend Analysis.

Lundberg A, Lundberg A, Soetikno A, Wu S, Ozer E, Welch S JMIR Public Health Surveill. 2025; 11:e53214.

PMID: 39804185 PMC: 11890137. DOI: 10.2196/53214.

Design, Synthesis and Biological Exploration of Novel -(9-Ethyl-9-Carbazol-3-yl)Acetamide-Linked Benzofuran-1,2,4-Triazoles as Anti-SARS-CoV-2 Agents: Combined Wet/Dry Approach Targeting Main Protease (M), Spike Glycoprotein and RdRp.

Zahoor A, Munawar S, Ahmad S, Iram F, Anjum M, Khan S Int J Mol Sci. 2024; 25(23).

PMID: 39684420 PMC: 11641759. DOI: 10.3390/ijms252312708.

References

Goncalves-Sa J . In the fight against the new coronavirus outbreak, we must also struggle with human bias. Nat Med. 2020; 26(3):305. PMC: 7073250. DOI: 10.1038/s41591-020-0802-y. View

Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S . 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27. PMC: 7102618. DOI: 10.1016/j.jgar.2020.02.021. View

de Wit E, van Doremalen N, Falzarano D, Munster V . SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14(8):523-34. PMC: 7097822. DOI: 10.1038/nrmicro.2016.81. View

Prem K, Liu Y, Russell T, Kucharski A, Eggo R, Davies N . The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020; 5(5):e261-e270. PMC: 7158905. DOI: 10.1016/S2468-2667(20)30073-6. View

Stoye E . China coronavirus: how many papers have been published?. Nature. 2021; . DOI: 10.1038/d41586-020-00253-8. View

Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P . Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and.... Evid Based Complement Alternat Med. 2018; 2018:5813095. PMC: 5949172. DOI: 10.1155/2018/5813095. View

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

10.

Kuiken T, Fouchier R, Schutten M, Rimmelzwaan G, van Amerongen G, van Riel D . Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003; 362(9380):263-70. PMC: 7112434. DOI: 10.1016/S0140-6736(03)13967-0. View

11.

Lai M, Cavanagh D . The molecular biology of coronaviruses. Adv Virus Res. 1997; 48:1-100. PMC: 7130985. View

12.

Hunter J, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K . Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi. Emerg Infect Dis. 2016; 22(4):647-56. PMC: 4806977. DOI: 10.3201/eid2204.151615. View

13.

Weiss S, Navas-Martin S . Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005; 69(4):635-64. PMC: 1306801. DOI: 10.1128/MMBR.69.4.635-664.2005. View

14.

de Groot R, Baker S, Baric R, Brown C, Drosten C, Enjuanes L . Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87(14):7790-2. PMC: 3700179. DOI: 10.1128/JVI.01244-13. View

15.

Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M . The 2019-new coronavirus epidemic: Evidence for virus evolution. J Med Virol. 2020; 92(4):455-459. PMC: 7166400. DOI: 10.1002/jmv.25688. View

16.

Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

17.

Kudo E, Song E, Yockey L, Rakib T, Wong P, Homer R . Low ambient humidity impairs barrier function and innate resistance against influenza infection. Proc Natl Acad Sci U S A. 2019; 116(22):10905-10910. PMC: 6561219. DOI: 10.1073/pnas.1902840116. View

18.

LESTER Jr W . The influence of relative humidity on the infectivity of air-borne influenza A virus, PR8 strain. J Exp Med. 1948; 88(3):361-8. PMC: 2135823. DOI: 10.1084/jem.88.3.361. View

19.

Warren-Gash C, Fragaszy E, Hayward A . Hand hygiene to reduce community transmission of influenza and acute respiratory tract infection: a systematic review. Influenza Other Respir Viruses. 2012; 7(5):738-49. PMC: 5781206. DOI: 10.1111/irv.12015. View

20.

Anderson R, Fraser C, Ghani A, Donnelly C, Riley S, Ferguson N . Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004; 359(1447):1091-105. PMC: 1693389. DOI: 10.1098/rstb.2004.1490. View